Oncolytics Biotech(R) Inc. Announces Publication Of Research On Synergistic Activity Of Reovirus And Chemotherapy In NSCLC
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") reported today that Dr. Shizuko Sei et al. published the results of their work examining reovirus and chemotherapy against human non-small cell lung cancer (NSCLC). The paper, entitled "Synergistic Antitumor Activity of Oncolytic Reovirus and Chemotherapeutic Agents in Non-Small Cell Lung Cancer Cells" appears online in the July 14, 2009 issue of Molecular Cancer.
Mental Health
Pages: 1 [2]
Palliative Care Research To Benefit From $1.5 Million Award
of California, San Francisco - Alexander K. Smith, M.D., MPH, is an assistant professor of medicine. Dr. Smith will conduct a study using a nationally representative survey linked with Medicare Data to describe the characteristics of elderly patients seen in the emergency department in the last 6 months of life and will use direct observation and survey methodology to examine communication about goals of care among a diverse group of seriously ill elders, their family caregivers, and emergency department providers. "We are truly enthusiastic over the large number of qualified and promising investigators that have applied for the pilot project support grants and junior faculty career development awards over the past three years," said Dr. Diane E. Meier, Chair of the NPCRC"s Scientific Advisory Board, Director of the Center to Advance Palliative Care, and the Hertzberg Palliative Care Institute at Mount Sinai School of Medicine. "Based on the progress and achievements of the current NPCRC and American Cancer Society grantees, we now look forward to opening more doors for additional investigators to advance the scientific field of palliative care." Further details about the NPCRC and ACS 2009 Grantees and their research projects are available at http://www.npcrc.org/grantees/. David Sampson American Cancer SocietyPages: 1 [2]